文献速递心力衰竭与心肌病血脂与心血管预防

鉴定与检查点抑制剂诱导的心肌炎相关的致病性免疫细胞亚群

Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.
PubMed 文献 · Circulation · 2022-06-28

该研究通过质谱流式细胞术和单细胞多组学技术,在52例个体(含8例ICI心肌炎患者)及Pdcd1-/-小鼠模型中,发现ICI心肌炎患者外周血中克隆性细胞毒性CD8+ Temra细胞显著扩增,并高表达CCL5/CCL4/CCL4L2趋化因子,小鼠血液和心脏中亦见类似效应CD8+细胞扩增,提示这些细胞及趋化因子可能成为诊断和治疗靶点。

要点

  • ICI心肌炎患者外周血中细胞毒性CD8+ Temra细胞显著扩增且呈克隆性。
  • 扩增的Temra CD8+细胞高表达CCL5/CCL4/CCL4L2,并与固有免疫细胞相互作用。
  • Pdcd1-/-小鼠自发性心肌炎模型再现了血液和心脏中效应CD8+细胞的扩增。

核心结论

  • 克隆性细胞毒性Temra CD8+细胞在ICI心肌炎患者血液中显著增加,与Pdcd1-/-小鼠心肌炎模型中的效应CD8+细胞扩增一致。
  • 这些扩增的效应CD8+细胞具有独特的转录改变,包括上调趋化因子CCL5/CCL4/CCL4L2,可能成为诊断或治疗靶点。

研究设计与样本

  • 研究采用质谱流式细胞术检测52例个体(29例ICI相关免疫不良事件患者,含8例ICI心肌炎,及23例健康对照)的外周血单核细胞。
  • 对30例患者/对照进行单细胞RNA测序、单细胞T细胞受体测序和CITE-seq多组学免疫表型分析。
  • 在MRL/Pdcd1-/-小鼠自发性心肌炎模型中行单细胞RNA测序/T细胞受体测序/CITE-seq以关联血液与心脏。

主要发现

  • 与对照组相比,ICI心肌炎患者中细胞毒性CD8+ Temra细胞扩增,且T细胞受体测序显示这些细胞呈克隆性扩增。
  • 转录组分析证实这些Temra CD8+克隆具有高度活化和细胞毒性表型。
  • 纵向研究显示,糖皮质激素治疗2个月后,这些Temra CD8+细胞进展为耗竭表型。
  • 差异表达分析显示克隆扩增的Temra CD8+细胞中促炎趋化因子CCL5/CCL4/CCL4L2表达升高,配体受体分析显示其与单核/巨噬细胞、树突状细胞和中性粒细胞等固有免疫细胞相互作用,且缺乏关键抗炎信号。
  • 在Pdcd1-/-小鼠自发性心肌炎模型中,血液和心脏中均发现类似的细胞毒性克隆效应CD8+细胞扩增。

临床怎么用

  • ICI心肌炎患者外周血中克隆性细胞毒性Temra CD8+细胞及趋化因子CCL5/CCL4/CCL4L2可能作为诊断或治疗靶点,用于减少威胁生命的免疫相关不良事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immune checkpoint inhibitors (ICIs) are monoclonal antibodies used to activate the immune system against tumor cells. Despite therapeutic benefits, ICIs have the potential to cause immune-related adverse events such as myocarditis, a rare but serious side effect with up to 50% mortality in affected patients. Histologically, patients with ICI myocarditis have lymphocytic infiltrates in the heart, implicating T cell-mediated mechanisms. However, the precise pathological immune subsets and molecular changes in ICI myocarditis are unknown. METHODS: To identify immune subset(s) associated with ICI myocarditis, we performed time-of-flight mass cytometry on peripheral blood mononuclear cells from 52 individuals: 29 patients with autoimmune adverse events (immune-related adverse events) on ICI, including 8 patients with ICI myocarditis, and 23 healthy control subjects. We also used multiomics single-cell technology to immunophenotype 30 patients/control subjects using single-cell RNA sequencing, single-cell T-cell receptor sequencing, and cellular indexing of transcriptomes and epitopes by sequencing with feature barcoding for surface marker expression confirmation. To correlate between the blood and the heart, we performed single-cell RNA sequencing/T-cell receptor sequencing/cellular indexing of transcriptomes and epitopes by sequencing on MRL/Pdcd1-/- (Murphy Roths large/programmed death-1-deficient) mice with spontaneous myocarditis. RESULTS: Using these complementary approaches, we found an expansion of cytotoxic CD8+ T effector cells re-expressing CD45RA (Temra CD8+ cells) in patients with ICI myocarditis compared with control subjects. T-cell receptor sequencing demonstrated that these CD8+ Temra cells were clonally expanded in patients with myocarditis compared with control subjects. Transcriptomic analysis of these Temra CD8+ clones confirmed a highly activated and cytotoxic phenotype. Longitudinal study demonstrated progression of these Temra CD8+ cells into an exhausted phenotype 2 months after treatment with glucocorticoids. Differential expression analysis demonstrated elevated expression levels of proinflammatory chemokines (CCL5/CCL4/CCL4L2) in the clonally expanded Temra CD8+ cells, and ligand receptor analysis demonstrated their interactions with innate immune cells, including monocytes/macrophages, dendritic cells, and neutrophils, as well as the absence of key anti-inflammatory signals. To complement the human study, we performed single-cell RNA sequencing/T-cell receptor sequencing/cellular indexing of transcriptomes and epitopes by sequencing in Pdcd1-/- mice with spontaneous myocarditis and found analogous expansions of cytotoxic clonal effector CD8+ cells in both blood and hearts of such mice compared with controls. CONCLUSIONS: Clonal cytotoxic Temra CD8+ cells are significantly increased in the blood of patients with ICI myocarditis, corresponding to an analogous increase in effector cytotoxic CD8+ cells in the blood/hearts of Pdcd1-/- mice with myocarditis. These expanded effector CD8+ cells have unique transcriptional changes, including upregulation of chemokines CCL5/CCL4/CCL4L2, which may serve as attractive diagnostic/therapeutic targets for reducing life-threatening cardiac immune-related adverse events in ICI-treated patients with cancer.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Zhu H, Galdos FX, Lee D, et al. Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis. Circulation. 2022. PMID: 35762356. doi:10.1161/CIRCULATIONAHA.121.056730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。